Abstracts – BRASS Study

2019

Andemeskel A, Feathers V, Iannaccone C, Cui J, Shadick NA. The Association Between Omega-3 Supplementation and Disease Activity in a Rheumatoid Arthritis (RA) Observational Cohort.
Curtis JR, Weinblatt ME, Saag K, Bykerk V, Charles-Schoeman, Fiore S, St. John G, Kimura T, Zheng S, Bingham C, Wright G, Bergman M, Nola K, Furst DE, Shadick N. Exploring Heterogeneity in Rheumatoid Arthritis: Patient Profiling Through Principal Component and Cluster Analysis of the BRASS Registry.
Curtis JR, Brahe CH, Østergaard M, Lund Hetland M, Hambardzumyan K, Saevarsdottir S, Wang X, Flake II DD, Sasso EH, Huizinga TW. Predicting Risk for Radiographic Damage in Rheumatoid Arthritis: Comparative Analysis of the Multi-Biomarker Disease Activity Score and Conventional Measures of Disease Activity in Multiple Studies.
Huang S, He X, Doyle TJ, Zaccardelli A, Marshall A, Friedlander HM, Blaustein R, Smith E, Iannaccone CK, Mahmoud TG, Weinblatt ME, Dellaripa P, Shadick NA, Sparks J. Association of Rheumatoid Arthritis-related Autoantibodies with Pulmonary Function Test Abnormalities in a Prospective Rheumatoid Arthritis Registry.
Mahmoud TG, Huang J, Frits M, Iannaccone C, Bykerk V, Bingham III CO, Weinblatt M, Shadick N. Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, & Medication Change.

2018

Alemao E, Bryson J, Iannaccone CK, Frits M, Shadick NA, Weinblatt M. Association of Shared Epitope and Poor Prognostic Factors in RA.
Shadick NA, Weinblatt ME, Iannaccone CK, Frits M, Davis T, Young C, Collier DH, Gharaibeh M, Stolshek BS. Characteristics of Patients and Predictors of Composite Disease Activity Scores for Switching to Monotherapy Vs Continuing TNF Inhibitor and Methotrexate Combination Therapy in RA: A Retrospective Analysis of the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry.
Huang S, Doyle T, Marshall A, Iannaccone CK, Huang J, Weinblatt ME, Dellaripa P, Karlson E, Shadick NA, Sparks JA. Chest Computed Tomography Abnormalities in Patients with Rheumatoid Arthritis By Serologic Status.
Liao K, Huang J, Cremone G, Lam E, Yang N, Playford M, Iannaccone CK, Coblyn J, Massarotti E, Weinblatt ME, Shadick NA, Mehta N, Plutzky J. Divergent Patterns of Cardiovascular Risk in Biomarkers of Lipid and Subclinical Myocardial Injury during Increased Inflammation in Rheumatoid Arthritis.
Alemao E, Saini Y, Bao Y, Rao A, Iannaccone CK, Frits M, Weinblatt ME, Shadick NA. Do Anti-Citrullinated Proteins Antibodies and Anti-Sjogren’s-Syndrome-Related-Antigen a Double Positive Patients with Secondary Sjogren’s Syndrome and RA Have Higher Joint Disease Activity?
Alemao E, Elbez Y, Saini Y, Connolly SE, Rao A, Iannaccone CK, Weinblatt ME, Shadick NA. Does Anti-Citrullinated Protein Antibody Status Modify Treatment Effect of Certain Biologic DMARDS?
Sparks JA, Doyle T, Huang J, Pan B, Fletcher E, Gill R, Hatabu H, Nishino M, Murphy D, Mahmoud T, Iannaccone CK, Frits M, Lu B, Rosas IO, Dellaripa P, Weinblatt ME, Karlson E, Shadick NA. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically-Apparent Interstitial Lung Disease: A Prospective Cohort Study.
Shadick NA, Iannaccone CK, Katz P, Maica GL, Coblyn J, Weinblatt ME, Cui J. The Impact of Exercise and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study.
Alemao E, Saini Y, Bao Y, Rao A, Iannaccone CK, Weinblatt ME, Shadick NA. The Joint Disease Burden with Secondary Sjogren’s Syndrome and RA Compared to Patients with RA Only.

2017

Warren K, Derbeneva O, Flores F, Frits M, Healy J, Iannaccone C, Khalid O, Morampudi K, Shadick N, Weinblatt M, Wijesuriya H, Terbrueggen R. Social Media Based, Direct-to-Patient Study Designed for Development of “from Home” Testing for Rheumatoid Arthritis Patients Is Feasible and Engaged Individuals with Distinct Clinical Characteristic.
Iannaccone C, Frits M, Mahmoud T, Maica G, Coblyn J, Weinblatt M, Shadick N. Characteristics of Rheumatoid Arthritis Patients Who Have a DMARD Interruption and the Impact of Using a Bridging Medication on Clinical and Patient Reported Outcomes.
Mahmoud T, Frits M, Iannaccone C, Maica G, Bykerk V, Weinblatt M, Shadick N. FLARE-RA Instrument Detects RA Flares Independent of Disease Activity.
Maica G, Frits M, Iannaccone C, Mahmoud T, Bingham C, Bykerk V, Weinblatt M, Shadick N. Understanding the Differences in Patient Definitions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.
Sparks J, Doyle T, Pan B, Iannaccone C, Frits M, Dellaripa P, Rosas I, Lu B, Weinblatt ME, Shadick NA, Karlson EW. Incidence and Predictors of Dyspnea on Exertion in a Prospective Cohort of Patients with Rheumatoid Arthritis.
Frits M, Bradwin G, Shadick N, Iannaccone C, Weinblatt M, Rifai N, Liao K. Factors Associated with TNF Receptor 2 Levels Above Measurable Range in Rheumatoid Arthritis.
Curtis JR, Flake DD, Weinblatt M, Shadick NA, Østergaard M, Hetland ML, Brahe CH, Hwang YG, Furst DE, Strand V, Etzel CJ, Pappas DA, Wang X, Hwang CC, Sasso EH, Gutin A, Hitraya E, Lanchbury JS. Development of an Adjusted Multi-Biomarker Disease Activity (MBDA) Score for Rheumatoid Arthritis (RA) That Accounts for Age, Sex and Adiposity, with Subsequent Evaluation of Ability to Predict Risk for Radiographic Damage.

2016

Ahmed H, Alemao E, Guo Z, Frits M, Weinblatt ME, Shadick NA. Association of Anti-Citrullinated Protein Antibody Positivity and Titer Levels to Low Hand BMD, and the Consequence of Low Hand BMD on DAS28 (CRP) Remission in Established RA: Findings from a US Observational Cohort.
Alemao E, Guo Z, Burns L, Frits M, Coblyn J, Weinblatt M, Shadick NA. Evaluation of the Association Between C-Reactive Protein and Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: Analysis of Two Clinical Practice Data Sets.
Iannaccone C, Mahmoud T, Cui J, Weinblatt M, Shadick NA. Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients.
Tedeschi SK, Frits M, Iannaccone C, Weinblatt M, Shadick NA, Bermas B. Rheumatoid Arthritis Flares and Pregnancy Outcomes Among Women in a Longitudinal Registry.
Mahmoud T, Frits M, Iannaccone C, Bykerk VP, Bingham C, Weinblatt M, Shadick NA. Correlates of Successful RA Flare Management: The Role of Clinician-Driven Treatment, Home-Based Strategies, and Medication Change.
Shadick NA, Gerlanc N, Frits M, Stolshek B, Brady B, Iannaccone C, Collier D, Cui J, Mutebi A, Weinblatt M. The Longitudinal Impact of Biologic Use on Disability within a RA Registry.

2015

2015 Abstracts – Accepted for Presentation at the American College of Rheumatology Conference – San Francisco, CA

Kim H, Cui J, Frits M, Iannaccone C, Shadick NA, Weinblatt ME, Lee YC. Fibromyalgia Predicts Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients.
Liao KP, Cui J, Rhodes C, Lahey LJ, Playford MP, Frits M, Iannaccone C, Coblyn JS, Weinblatt ME, Shadick NS, Mehta NN, Sokolove J. The Association Between HDL Cholesterol Efflux Capacity, Citrullinated ApoA1 and Anti-Citrullinated ApoA1 Antibodies in Rheumatoid Arthritis.
Mahmoud T, Iannaccone C, Cui J, Lee YC, Weinblatt ME, Shadick NA. The Association between Social Network, Disease Activity, and Pain in Rheumatoid Arthritis.
Radner H, Studenic P, Cohan S, Shadick N, Iannaccone C, Lie E, Kvien TC, Aletaha D, Smolen JS. Different Wording of the Patient Global Leads to Different Rating of Disease Activity.
Alemao E, Gandhi K, Iannaccone C, Frits M, Shadick N, Weinblatt M. Evaluation of Anti-cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice and its Association With Disease Activity.
Alemao E, Gandhi K, Iannaccone C, Frits M, Shadick N, Weinblatt M. Evaluation of the Impact of Disease-Modifying Antirheumatic Drugs on the Levels of Anti-cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice.
Alemao E, Joo S, Frits M, Iannaccone C, Shadick N, Weinblatt M. Baseline Characteristics and Changes in Disease Activity at 12 Months in Patients Treated with Abatacept Versus Other Biologic Disease-Modifying Antirheumatic Drugs in Clinical Practice Setting.
Radner H, Yoshida K, Tedeschi SK, Frits M, Iannaccone C, Shadick N, Weinblatt M, Aletaha D, Smolen JS, Solomon D. Different Perception of Disease Activity in Multimorbid Rheumatoid Arthritis Patients.

2014

2014 Abstracts- Accepted for Presentation at the American College of Rheumatology Conference – Boston, MA

Iannaccone C, Cui J, Coblyn J, Liao K, Weinblatt M, Shadick N. The Association of Body Mass Index (BMI) and Radiographic Progression of Joint Disease in Rheumatoid Arthritis (RA).
Iannaccone C, Cui J, Coblyn J, Weinblatt M, Shadick N. Predictors of Deterioration in Subjective Cognition: Results from a Rheumatoid Arthritis (RA) Observational Cohort Study.
Alemao E, Joo S, Allison PD, Al M, Rutten M, Banerjee S, Iannaccone C, Frits ML, Shadick N, Weinblatt M, Liao KP. Comparisons of Quality of Life, Resource Use and Physical Functioning in RA Patients Classified as High, Moderate or Low Risk for Rapid Radiographic Progression.
Sasso EH, Wu G, Hwang CC, Weinblatt M, Shadick N, Alexander C, Seguarado OG. The Multi-Biomarker Disease Activity Score as a Predictor of Radiographic Progression in a Longitudinal Registry of Patients with Rheumatoid Arthritis.
Wohlfahrt A, Cui J, Frits M, Iannaccone C, Coblyn J, Weinblatt M, Shadick N, Lee YC. Early Birds Versus Night Owls: Morning/Evening Preference and Its Association with Sleep Problems, Fatigue, and Emotional Well-Being Among RA Patients.
Fine AS, Frits M, Cui J, Iannaccone C, Coblyn J, Weinblatt M, Lee Y. Inflammatory Biomarkers, Sleep Quantity and Sleep Quality in Rheumatoid Arthritis.
Alemao E, Joo S, Kawabata H, Banerjee S, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME. Benefits of Early Onset of DAS2(CRP) <2.6 on Physical Functioning, Quality of Life and Resource Use Among RA Patients in a Clinical Practice Setting.
Liao K, Playford M, Bradwin G, Coblyn J, Iannaccone C, Rifai N, Weinblatt M, Shadick N, Mehta NN, The Association Between a Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis.

2013

2013 Abstracts – Presented at the American College of Rheumatology Conference – San Diego, CA

Brown LE, Frits M, Iannaccone C, Weinblatt ME, Shadick NA, Liao KP. Clinical Characteristics of Rheumatoid Arthritis Patients with Secondary Sjögren’s Syndrome and Association with Joint Damage.
Lee YC, Hackett J, Alexander C, Frits M, Iannaccone CK, Shadick NA, Weinblatt ME, Seguarado OG, Sasso EH. Application of a Multi-Biomarker Disease Activity (Vectra^® DA) Score for Assessing Rheumatoid Arthritis Patients with Fibromyalgia or Low CRP.
Sung YK, Kazuki Y, Prince FHM, Frits M, Choe JY, Chung WT, Lee J. Quality of Life In Rheumatoid Arthritis: National Comparison Study Between US and South Korea.
Lee YC, Frits M, Iannaccone CK, Weinblatt ME, Shadick NA, Williams DA, Cui J. Subgrouping of Rheumatoid Arthritis Patients Based on Pain, Fatigue, Inflammation and Psychosocial Factors.

2012

2012 Abstracts – Presented at the American College of Rheumatology Conference – Washington, DC

Cui J, Shadick NA, Liao KP, Weinblatt ME, Plenge RM, Karlson EW. Aggregated Genetic Information Explains Variations on Hand Radiographic Scores in Rheumatoid Arthritis Patients.
Lillegraven S, Shadick N, Jabbar-Lopez Z, Potapov A, Frits ML, Iannaccone CK, Haavardsholm EA, Kvien TK, Weinblatt ME, Solomon DH.Progressive Radiographic Joint Damage in Established Rheumatoid Arthritis: Common and Strongly Associayed with Seropositivity.
Desai S, Yazdany J, Shadick NA, Lillegraven S, Liu C, Frits ML, Norton T, Coblyn J, Weinblatt M, Solomon D.Physician Variation in Documentation of Rheumatoid Arthritis Quality Measures and Evaluation of Relationship with Radiographic Progression.
Lee Y, Frits M, Iannaccone C, Weinblatt M, Shadick N.Diagnosis of Secondary Fibromyalgia in an Established Rheumatoid Arthritis Cohort.

2011

2011 Abstracts – Presented at the American College of Rheumatology Conference – Chicago, IL

Lillegraven S, Prince FHM, Shadick NA, Haavardsholm EA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH. The Performance of Matrix-Based Risk Models for Rapid Radiographic Progression in an Observational Cohort of Established Rheumatoid Arthritis Patients.
Prince FHM, Lillegraven S, Bykerk VP, Shadick NA, Lu B, Frits M, Iannaccone CK,Weinblatt ME, Solomon DH. The Relationship Between Time in Remission and Functional Status in Rheumatoid Arthritis.

2011 Abstracts – Presented at the European League against Rheumatism Conference, London, UK

Bykerk VP, Shadick NA, Frits M, Iannaconne C, Bingham C, Weinblatt M, Solomon D. Patients with Rheumatoid Arthritis Frequently Flare During the Course of Disease.
Prince FHM, Lillegraven S, Bykerk VP, Shadick NA, Lu B, Frits M, Iannaccone CK,Weinblatt ME, Solomon DH. The Relationship Between Time in Remission and Functional Status in Rheumatoid Arthritis.
Lillegraven S, Prince FH, Bykerk VP, Shadick NA, Lu B, Frits ML, Iannaccone CK, Haavardsholm EA, Kvien TK, Weinblatt ME, Solomon DH. Radiological Progression in Remission by the New ACR/EULAR Criteria for Remission: A Comparison to Other Established Remission Criteria.
Lillegraven S, Prince FHM, Bykerk VP, Shadick NA, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH. Time in Remission Influences Radiological Progression in RA Patients.

2010

2010 Abstracts – Presented at the American College of Rheumatology Conference – Atlanta, GA

Vivian P. Bykerk, Daniel H. Solomon, Clifton Bingham III, Michelle Frits, Christine Iannaccone, Michael E. Weinblatt, Nancy A. Shadick. The role of objective measures vs. patient reported outcomes (PROs) as a reflection of flares in patients with RA: Results from the Brigham RA Sequential Study (BRASS)
Christine Iannaccone, Anne Fossel, Hsun Tsao, Jing Cui, Michael Weinblatt, Nancy Shadick. Factors associated with Attrition in a Longitudinal Rheumatoid Arthritis (RA) Registry
Yvonne C Lee, Jing Cui, Bing Lu, Michelle L Frits, Christine K Iannaconne, Nancy A Shadick, Michael E Weinblatt, Daniel H Solomon. Prevalence and Predictors of Pain in Rheumatoid Arthritis Patients in DAS28 Remission
Katherine P Liao, Jing Cui, Michael E Weinblatt, Christine Iannaccone, Nancy Shadick, Robert M Plenge, Daniel H Solomon, and Elizabeth W Karlson. The Associations Between RA Genetic Risk Alleles and Seropositive But Non-Erosive Rheumatoid Arthritis
Femke H.M. Prince, Vivian P. Bykerk, Nancy A. Shadick, Jing Cui, Michelle Frits, Christine K. Iannaccone, Michael E. Weinblatt, Daniel H. Solomon. Durability of clinical remission in rheumatoid arthritis based on various criteria
Femke H.M. Prince, Vivian P. Bykerk, Nancy A. Shadick, Jing Cui, Michelle Frits, Christine Iannaccone, Michael E. Weinblatt, Daniel H. Solomon. Time in sustained clinical remission in rheumatoid arthritis
Melanie Zibit, Nancy Sowell, Meghan Courtney, Jing Cui, Anne Fossel, Christine Iannaccone, Margo Hanlan, Hsun Tsao, Michael Weinblatt, Nancy Shadick. Does a Rheumatoid Arthritis (RA) peer support program impact disease outcomes?

2009

2009 Abstracts – Presented at the American College of Rheumatology Conference – Philadelphia, PA

Christine Iannaccone, Michelle Frits, Jing Cui, Michael Weinblatt, Nancy Shadick. Prevalence of alcohol consumption among Rheumatoid Arthritis (RA) patients on Methotrexate (MTX) and impact on liver function tests
Maura Iversen. Predictors of PT Service Use in RA Patients
Jing Cui, AL DeStefano, Michael E. Weinblatt, Roeber M. Plenge, Nancy A. Shadick, Elizabeth W. Karlson. Genome Wide Association Study of Genetic Predictors of Quantitative Anti-CCP Level in RA
J. Cui, S. Saevarsdottir, B. Thompson, S. Raychaudhuri, P. Gregersen, F. Batliwalla, N. De Vries, MM Herenius, Paul P. Tak, C.F. Allaart, N. Shadick, M. E. Weinblatt, A. Barton, A. Morgan, L. Klareskog, L. Alfredsson, S.L. Bridges Jr., L.A. Criswell, L. Padyukov, T.W.J. Huizinga, R.E.M. Toes, E. Karlson, R.M. Plenge. RA Risk Alleles as Correlates of Response to Anti-TNF Therapy in RA
Katherine P. Liao, Michael E. Weinblatt, Jing Cui, Hiroshi Yoshioka, Christine Iannaccone, Lori B. Chibnik, Bing Lu, Jonathan S. Coblyn, Nancy A. Shadick, Daniel H. Solomon Clinical factors that predict erosion-free status in rheumatoid arthritis
Y. Shen, N. Knowlton, M. Turner, C. Sutton, D. Smith4, D. Chernoff, L. Hesterberg, R. Roubenoff, N.A. Shadick, M. Weinblatt6, G. Cavet and M. Centola Stepwise Development of a Multi-Protein Biomarker Index of RA Disease Activity

2007

2007 Abstracts – Presented at the American College of Rheumatology Conference – Boston, MA

Kerri L. Batra, Jing Cui, Roberta Glass, Daniel H. Solomon, Nancy E. Maher, Michael E. Weinblatt, Nancy A. Shadick Contemporary Trends in Rheumatoid Arthritis Disease Activity Reduction and Medication Use
Kerri L. Batra, Jing Cui, Roberta Glass, Nancy E. Maher, Daniel H. Solomon, Nancy A. Shadick . Evaluation of Selected Rheumatoid Arthritis Activity Scores for Office Based Assessment
Cui J, Karlson EW, DeStefano AL, Maher NE, Glass RJ, Izmailova E, Roubenoff R, Weinblatt ME, Parker A, Plenge RM, Shadick. Whole genome association study for quantitative CCP titer in rheumatoid arthritis
Roberta J Glass, Jing Cui, Elizabeth W Karlson, Nancy E Maher, Michael E Weinblatt, Nancy A Shadick.Can Pain Sensitivity SNPs be replicated in Rheumatoid Arthritis (RA) Patients?
Izmailova E, Pickard M, Paz N, Fitzgerald M1, Narang J, Maher N, Healy A, Jaffee B, Fox I, Shadick NA, Roubenoff R, Weinblatt ME , Parker A.. Biomarkers of Rheumatoid Arthritis Disease Activity: A Translational Approach
Yvonne C. Lee, Jing Cui, Karen H. Costenbader, Robert M. Plenge, Nancy A. Shadick, Michael E. Weinblatt, Nancy E. Maher, Elizabeth W. Karlson. Association between ATIC, ITPA, AMPD1, MTR and MTRR Polymorphisms and Disease Activity in Rheumatoid Arthritis Patients on Methotrexate
Robert Plenge, Whole Genome Association Study in Rheumatoid Arthritis Implicates TRAF1-C5 as a New Susceptibility Locus

2006

2006 Abstracts – Presented at the American College of Rheumatology Conference – Washington, DC

Heller JE, Agarwal SK, Chibnik LB, Maher NE, Solomon DH, Parker A, Roubenoff R, Plenge RM, Weinblatt ME, Shadick NA, PTPN22 and HLA SE Are Not Associated with Discontinuation of TNF? Inhibitors or Methotrexate in a Large RA Cohort
Izmailova E, Pickard M, Narang J, Paz N, Shadick NA, Weinblatt ME, Roubenoff R, Parker A. Biomarkers of Rheumatoid Arthritis Disease Activity in Mouse and Man: A Translational Approach
Pickard MD, Narang J, Izmailova ES, Weinblatt ME, Shadick NA, Bryant B, Roubenoff R, Parker A. Protein Biomarkers that Predict Changes in Rheumatoid Arthritis (RA) Disease Activity
Parker A, Izmailova E, Pickard M, Bryant B, Narang J, Maier A, Coblyn JS, Shadick NA, Roubenoff R, Weinblatt MEExpression of NFB-regulated genes associates with RA disease activity and is altered by anti-TNF treatment but not by methotrexate
Plenge RM, Cotsapas C, Purcell S, Mailler J, Blumensteil B, DeFelice M, Gabriel S, Daly MJ, Parker A, Roubenoff R, Klareskog L, Gregersen P, Maher N, Glass R, Karlson EW, Coblyn J, Weinblatt M, Lee D, Brenner M, Shadick N, Altshuler D. Whole genome association study using 116,204 SNPs in Rheumatoid Arthritis
Nancy A. Shadick, Roberta Glass, Nancy E. Maher, Michael E. Weinblatt, Sonali DeSai, Lori Chibnik, Daniel Solomon, Ronenn Roubenoff, Alex Parker, Elizabeth W. Karlson.The Anti-cyclic Citrullinated Antibody Titer Does Not Predict Disease Activity in Rheumatoid Arthritis
Mei-Chun Wu, Roberta Glass, Nancy Maher, Nancy Shadick, Maura D. Iversen.Association between disease activity, attitudes toward exercise and exercise in patients with Rheumatoid Arthritis

2004

2004 Abstracts – Presented at the American College of Rheumatology Conference – San Antonio, Texas

E Benito-Garcia, NE Maher, HM Matthews, JA Bilics, J Karlson, ME Weinblatt, NA Shadick. Dietary Caffeine Intake and Methotrexate Efficacy in Rheumatoid Arthritis
Foti A, Maher NE, Shadick NA, Ginsburg GS, Lekstrom-Himes J, Coblyn J Anderson R, Weinblatt ME, Parker A. Physician-Patient Concordance on Joint Examinations: Can the Standards for Tracking Patient Response to Medication be Expanded?
Foti A, Lichter D, Shadick NA, Maher NE, Ginsburg GS, Lekstrom-Himes J, Meyer J1, Weinblatt ME, Parker A. Retrospective Genetic Analysis of Efficacy and Adverse Events in a Rheumatoid Arthritis Population Treated with Methotrexate and Anti-TNF-?
Izmailova ES, Kingsbury GA, Grant E, Briskin M, Parker A, Meyers J, Ginsburg GS, Weinblatt ME, Shadick NA, Kishimoto TK, Gutierrez-Ramos J-C, Lekstrom-Himes J, & Chun M. Serological biomarkers that correlate with ACR response criteria in RA
NE Maher, JA Bilics, JE Karlson, HM Matthews, NA ShadickDeterminants of DMARD Medication Change in Rheumatoid Arthritis (RA); the Effect of Physician – Patient Agreement and Measures of Disease Activity
Parker A, Foti A, Lichter D, Maher NE, Meyer J, Ginsburg GS, Lekstrom-Himes J, Weinblatt ME, Shadick NA. Rheumatoid Arthritis as a Polygenic Trait: Multiple Gene x Gene and Gene x Gender Interactions Influence Disease Risk and Age at Onset
Ryan M, Faron-Yowe L, Groves C, Pickard M, Singh A, Kingsbury GA, Briskin M, Kishimoto TK, Guitierez-Ramos JC, Weinblatt ME, Maier A, Coblyn J, Parker A, Ginsburg G, Lekstrom-Himes J, Chun M. Cell surface biomarkers that correlate with DAS28 improvement with MTX and/or anti-TNF treatment in RA
Shadick NA, Parker A, Solomon, D, Maher N, Meyer J, Lekstrom-Himes J, Ginsburg G, Bilics, J, Coblyn, JC, Anderson RJ, Weinblatt ME. . Clinical and Genetic variables associated with disease severity and risk correlate with radiographic changes in a cohort of subjects with rheumatoid arthritis(RA)
Shadick NA , Weinblatt ME, Maher NE, Solomon DS, Coblyn JC, Anderson RJ, Meyer J, Parker A, Chun M, Fedyk E, Bryce J, Singh A, Ginsburg G, and Lekstrom-Himes JA. Discovery and Validation of Multidimensional Biomarker Sets in a Large Single Site Rheumatoid Arthritis Patient Registry
Shadick NA, Weinblatt ME,, Maher N, Meyer J, Lekstrom-Himes J, Ginsburg G, Matthews, H, Bilics, J, Karlson, J, Coblyn, JC, Solomon D, Anderson RJ Parker A Genetic polymorphisms contribute to clinical markers as predictors of DAS remission in patients with rheumatoid arthritis(RA)
Shadick NA , Weinblatt ME, Maher NE, Solomon DS, Coblyn JC, Anderson RJ, Meyer J, Parker A, Chun M, Singh A, Ginsburg G, and Lekstrom-Himes JA. Therapeutic Response Biomarkers for Proof of Concept Clinical Trials: Discovery and Validation of Multidimensional Biomarker Sets in a Large Single Site Rheumatoid Arthritis Patient Registry
Singh AK, Lekstrom-Himes J , Meyer J , Ginsburg GS , Shadick NA , Maher NE , Weinblatt ME , Fedyk E , Parker A . Analysis of RA Symptom Severity using Transcriptional Profiling and Genetics